Matches 1 - 50 out of 310 1 2 3 4 5 6 7 >


Match Document Document Title
US20110218139 COMBINATION THERAPY AND METHODS FOR TREATING BACTERIAL BIOFILMS  
A combination therapy for treating a bacterial biofilm comprises a therapeutically effective amount of an antibiotic comprising an aminoglyco side or tetracycline, or a combination of two or more...
US20140371134 Dry Pharmaceutical Compositions for Topical Delivery of Oral Medications, Nasal Delivery and to Treat Ear  
In one aspect, a dry formulation for the effective administration of multiple medications simultaneously for one or more ailments may be provided. The dry formulations include one or more of the...
US20100331242 METHOD OF USING LECTINS FOR PREVENTION AND TREATMENT OF ORAL AND ALIMENTARY TRACT DISORDERS  
Infectious diseases caused by pathogenic microorganisms resident in the alimentary tract of humans and animals can be prevented and treated by administering to the alimentary tract of the human or...
US20140323391 BIOMARKERS FOR THE MOLECULAR CLASSIFICATION OF BACTERIAL INFECTION  
Disclosed herein are biomarkers useful for identifying and/or classifying bacterial infections in a subject.
US20110280893 SYNTHETIC LIPID A DERIVATIVE  
The invention provides functionalized monosaccharides and disaccharides suitable for use in synthesizing a lipid A derivative, as well as methods for synthesizing and using a synthetic lipid A...
US20120316104 USE OF BACTERIOPHAGE OUTER MEMBRANE BREACHING PROTEINS EXPRESSED IN PLANTS FOR THE CONTROL OF GRAM-NEGATIVE BACTERIA  
The present invention provides compositions and methods for killing or suppressing growth of Gram-negative bacteria that infect, infest or cause disease in plants, including pathogenic,...
US20110003734 PROTEINS AND POLYNUCLEOTIDES OF VIBRIO CHOLERAE  
Therapeutic, diagnostic and environmental monitoring methods employing proteins encoded by the rbmBCDEF gene cluster and by bap1.
US20140234397 TREATMENT OF KLEBSIELLA PNEUMONIAE WITH LIPOSOMALLY FORMULATED GLUTATHIONE  
The composition of the invention, liposomal glutathione, has been recently shown to have utility for having an antibiotic like effect on Klebsiella pneumonia cultures in vitro, and in vivo as...
US20150164984 Colicins for Treating Bacterial Infections  
The Invention relates to materials and methods for the treatment of conditions associated with bacterial biofilms, intracellular bacterial infections and/or adherent-invasive Escherichia coli...
US20120122768 ALGINATE OLIGOMERS FOR USE IN OVERCOMING MULTIDRUG RESISTANCE IN BACTERIA  
The invention provides a method of overcoming resistance to at least one antibiotic in a multidrug resistant bacterium, said method comprising contacting said bacterium with an alginate oligomer...
US20140235532 IMMUNOGENIC ESCHERICHIA COLI HEAT STABLE ENTEROTOXIN  
The present invention relates to methods and compositions for the treatment and prevention of diarrhea and diarrheal related diseases and disorders in both animals and humans. In some embodiments,...
US20140194346 PASTEURELLACEAE VACCINES  
The present invention relates to an N-glycosylated protein for treating and/or preventing bacterial Pasteurellaceae infection in a mammal or bird, wherein the protein is a Pasteurellaceae protein,...
US20120295839 METHOD OF TREATMENT AND PROPHYLAXIS OF BACTERIAL VAGINOSIS  
Methods of treatment or prophylaxis of bacterial vaginosis, prevention of recurrence of bacterial vaginosis and alleviation or prevention of symptoms or diagnostic criteria of bacterial vaginosis...
US20110144002 Use of AMPs for Treatment of UTI/Cystitis  
The present invention relates to methods for treating urinary tract infections, such as cystitis, with antimicrobial polypeptides polypeptides.
US20110014210 CHLAMYDIA VACCINE  
Compositions and methods for the treatment of Chlamydial infection are disclosed. The compositions provided include polypeptides that contain at least one antigenic portion of a Chlamydia antigen...
US20130310307 METHODS AND COMPOSITIONS FOR TREATMENT OF MULTIDRUG-RESISTANT BACTERIAL AND FUNGAL INFECTIONS  
The invention provides a method of killing an infectious microbe by administering an effective amount of transferrin to an individual having a microbial infection, wherein the transferrin has...
US20150238557 METHOD OF TREATMENT OR PROPHYLAXIS OF INFECTIONS OF THE EYE  
A microbial infection in an eye of a subject is treated or prevented by topically administering to the eye an effective amount of a macromolecule or a pharmaceutically acceptable salt thereof that...
US20050163764 Treatment with agonists of toll-like receptors  
Mammals are treated with agonists of bacterially-activated TLRs. The agonist are administered orally or mucosally. In one embodiment, the mammal treated is subject to a gastro-intestinal injury....
US20080085866 METALLO-DESFERRIOXAMINE COMPLEXES AND THEIR USE IN THE TREATMENT OF BACTERIAL INFECTIONS  
Methods for treating a bacterial infection by using a metallo-desferrioxamine complex.
US20110003001 BISMUTH-THIOLS AS ANTISEPTICS FOR EPITHELIAL TISSUES, ACUTE AND CHRONIC WOUNDS, BACTERIAL BIOFILMS AND OTHER INDICATIONS  
Compositions and methods, including novel homogeneous microparticulate suspensions, are described for treating acute wounds, chronic wounds and/or a wound or epithelial tissue surface that...
US20110206674 Yersinia SPP. Polypeptides and Methods of Use  
The present invention provides isolated polypeptides isolatable from a Yersinia spp. Also provided by the present invention are compositions that include one or more of the polypeptides, and...
US20110160124 ANTIMICROBIAL PROTEIN COMPOSITIONS AND PRODUCTION THEREFOR FROM MARINE BACTERIA  
Several bacterial species were isolated from marine segment obtained from seabed sediment at depths exceeding 1700 feet. At least four of the bacteria produced a compound that showed antibacterial...
US20130157932 NGAL AND URINARY TRACT INFECTION  
In some embodiments, the present invention is directed to compositions and methods for the treatment and prevention of urinary tract infections (UTIs) and urosepsis. In some embodiments, the...
US20130196900 ENHANCEMENT OF INNATE RESISTANCE TO INFECTION  
The present invention provides compounds and compositions that enhance the innate immune system. The present invention comprises methods of preventing, treating or ameliorating an infectious...
US20140170124 METHODS AND USES OF A MODIFIED CECROPIN FOR TREATING ENDOPARASITIC AND BACTERIAL INFECTIONS  
The present disclosure provides a modified cecropin protein comprising a cecropin or a variant thereof fused to a hydrophilic tail lacking a C-terminal glycine. The present disclosure also...
US20150018268 MULTIVALENT SYNTHETIC COMPOUNDS AS ANTIBIOTIC TREATMENT  
The present invention relates to the use of a multivalent synthetic compound, which is significantly more resistant to at least one protease than a standard peptide bond, for preparing a...
US20110152176 AGR-MEDIATED INHIBITION AND DISPERSAL OF BIOFILMS  
The present invention involves the use of activators of bacterial agr quoroum-sensing systems to block, inhibit or reverse biofilm formation. The biofilm may be located on an industrial or medical...
US20140274880 MOSQUITOCIDAL XENORHABDUS, LIPOPEPTIDE AND METHODS  
Provided is a bacterial strain which produces a family of mosquitocidal toxins, Xenorhabdus MT, on deposit with the American Type Culture Collection, PTA-6826, insecticidal compositions comprising...
US20140031275 METHODS OF ERADICATING BACTERIAL CELL POPULATIONS  
Disclosed herein are methods and compositions for the eradication of bacterial infections. In particular, methods and compositions are disclosed for the eradication of persister and slow growing...
US20070142392 Uses of rifamycins  
The invention features methods, compositions, and kits for treating prosthetic joint infections, foreign body infections, infectious arthritis, and osteomyelitis
US20150148286 POTENTIATION OF ANTIBIOTIC TREATMENT WITH A PROTEIN-LIPID COMPLEX  
Provided are compositions and methods for potentiating the effect of antibiotics. The compositions comprise a non-covalent complex of alpha-lactalbumin and fatty acid. The fatty acids are cis,...
US20120128701 COMPOSITIONS AND METHODS FOR THE REMOVAL OF BIOFILMS  
Methods of breaking down a biofilm or inhibiting, preventing or treating a microbial infection that produces a biofilm are disclosed, which involves administration of a polypeptide that has one or...
US20110160125 METHOD AND CULTURE MEDIUM FOR ENHANCED DETECTION OF MYCOBACTERIUM  
The present invention relates to an improved culture medium and method for the enhanced growth and detection of Mycobacterium growth. The invention further relates to an improved mycobacterial...
US20140093477 MODULATING BACTERIAL MAM POLYPEPTIDES IN PATHOGENIC DISEASE  
The disclosure relates to methods and compositions for preventing or inhibiting pathogenic bacterial infections in a subject caused by pathogenic bacteria expressing a multivalent adhesion...
US20120058936 COMPOSITIONS AND METHODS FOR ELIMINATION OF GRAM NEGATIVE BACTERIA  
Oral drug delivery formulations which specifically administer antibacterial agents to the ileum, caecum, and/or the colon, without significant administration elsewhere in the gastrointestinal...
US20120289456 ANTIMICROBIAL PROTEIN COMPOSITIONS AND USES THEREOF  
Several bacterial species were isolated from marine segment obtained from seabed sediment at depths exceeding 1700 feet. At least four of the bacteria produced a compound that showed antibacterial...
US20140206601 Methods and Pharmaceutical Compositions for the Treatment of Respiratory Tract Infections  
The present invention relates to methods and pharmaceutical compositions for the treatment of respiratory tract infections. More particularly, the present invention relates to a TLR5 agonist for...
US20130150286 METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF RESPIRATORY TRACT INFECTIONS  
The present invention relates to methods and pharmaceutical compositions for the treatment of respiratory tract infections. More particularly, the present invention relates to a TLR5 agonist for...
US20140082769 MOLECULES AND METHODS FOR INHIBITION AND DETECTION OF PROTEINS  
The present application belongs to the field of functional peptides and more particularly to the field of controlled protein aggregation. The invention discloses molecules of a peptide structure...
US20140187474 THERAPEUTIC USE OF MUCIN GLYCANS  
A therapeutic formulation containing mucin glycans derived from one or a number of nutritionally appropriate sources is described.
US20120251444 TREATMENT OF LIVER DISORDERS BY ADMINISTRATION OF RAP CONJUGATES  
The present invention relates to the use of receptor-associate protein (RAP) and fragments and variants thereof to improve delivery of therapeutic compounds to the liver and provides methods to...
US20080125365 ISOLATED COMPLEXES OF COVALENTLY CROSS-LINKED ENDOTOXIN AND MODIFIED MD-2  
Applicants have produced and isolated chemically cross-linked complexes of endotoxin and modified MD-2, and have developed methods of using these complexes.
US20120157371 HIGH PENETRATION PRODRUG COMPOSITIONS OF ANTIMICROBIALS AND ANTIMICROBIAL-RELATED COMPOUNDS  
The invention provides compositions of novel high penetration compositions (HPC) or high penetration prodrugs (HPP) of antimicrobials and antimicrobial-related compounds, which are capable of...
US20110020216 SCAFFOLDS FOR CELL COLLECTION OR ELIMINATION  
A device that includes a scaffold composition and a bioactive composition with the bioactive composition being incorporated therein or thereon, or diffusing from the scaffold composition such that...
US20120328568 COMPOSITIONS AND USES OF LECTINS  
The disclosure relates to uses of a purified or isolated lectin to kill bacteria, viruses, and other pathogens. In certain embodiments, the disclosure relates to method of treating or preventing...
US20150232517 MUTANT FRAGMENTS OF OspA AND METHODS AND USES RELATING THERETO  
The present invention relates to a polypeptide comprising a mutant fragment of an outer surface protein A (OspA), a nucleic acid coding the same, a pharmaceutical composition (particularly for use...
US20140010835 MUTANT FRAGMENTS OF OspA AND METHODS AND USES RELATING THERETO  
The present invention relates to a polypeptide comprising a mutant fragment of an outer surface protein A (OspA), a nucleic acid coding the same, a pharmaceutical composition (particularly for use...
US20110143992 Methods and Compositions Related to GHS-R Antagonists  
Disclosed herein are methods and compositions related to GHS-R antagonists.
US20120172285 METHODS AND COMPOSITIONS FOR SPECIFIC MODULATION OF MCL-1  
A series of stapled BCL-2 family peptide helices were identified as able to target the survival protein MCL-I with high affinity and a subset with unprecedented selectivity. Agents and methods for...
US20150126435 PRIMERS, ASSAYS AND METHODS FOR DETECTING AN E. COLI SUBTYPE  
Disclosed are primers, probes, and single nucleotide polymorphisms (SNP) specific to a distinct subclones of the E. coli sequence type 131 (ST131). Also disclosed are methods and assay kits useful...

Matches 1 - 50 out of 310 1 2 3 4 5 6 7 >